+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Primary Cells Market by Origin (Human Primary Cells, Animal Primary Cells), Type (Hematopoietic, Dermatocytes, Gastrointestinal, Hepatocytes, Lung, Renal, Musculoskeletal, Heart), End User, Region - Global Forecast to 2025

  • ID: 5157502
  • Report
  • October 2020
  • Region: Global
  • 176 Pages
  • Markets and Markets
The Global Primary Cells Market is Projected to Reach USD 1,613 Million by 2025 from USD 970 Million in 2020, at a CAGR of 10.7% during the Forecast Period.

FEATURED COMPANIES

  • AcceGen
  • BioIVT
  • Cell Biologics, Inc.
  • Epithelix Sàrl
  • Lonza
  • PPA Research Group, Inc.
  • MORE

Market growth is driven by the rising prevalence of cancer, the rapid growth in the biotechnology & biopharmaceutical industries, growing focus on R&D, recent developments in stem cell therapy, the increasing demand for monoclonal antibodies, and advantages of primary human cells over cell lines are the major factors driving the growth of the primary cells market.

The human primary cells accounted for the highest growth rate in the primary cells market, by origin, during the forecast period

Based on origin, the primary cells market is segmented into human and animal primary cells. The human primary cells segment accounted for the highest growth rate in the primary cells market in 2019. The increasing funding for the R&D of regenerative therapies, the rising incidence of cancer, and the growing application areas of human stem cells are the major factors driving the growth of this segment.

Hepatocytes segment accounted for the highest CAGR

Based on type, the primary cells market is segmented into hematopoietic cells, dermatocytes, gastrointestinal cells, hepatocytes, lung cells, renal cells, heart cells, musculoskeletal cells, and other primary cells. In 2019, the hepatocytes segment accounted for the highest growth rate. Increasing research funding by key pharma players, increasing incidence of liver cancer & pediatric liver diseases across the globe, and the emergence of new companies dedicated to liver therapeutics research are the major factors driving the growth of this segment.

Life science research companies segment accounted for the highest CAGR

Based on end-users, the primary cells market is segmented into life science research companies and research institutes. In 2019, the life science research companies segment accounted for the highest growth rate. This can be attributed to the increasing investments of companies in cell-based research, high adoption of primary cells in cell-based experiments, increasing cancer research in life science research companies, and the increasing number of R&D facilities globally.

Asia Pacific: The fastest-growing region primary cells market

The global primary cells market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. The Asia Pacific region is projected to grow at the highest CAGR during the forecast period in 2019. The growth in this region can be attributed to the increasing research activities in Asian countries, the availability of funding for research, a growing number of biobanks & research centers, rising prevalence of cancer, and recent developments in tissue engineering & stem cell therapy.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 20%, Tier 2 - 45%, and Tier 3 - 35%
  • By Designation: C-level - 30%, D-level - 20%, and Others - 50%
  • By Region: North America - 36%, Europe - 25%, Asia Pacific - 27%, and Rest of the World - 12%

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific, Inc. (US)
  • Merck KGaA (Germany)
  • Lonza (Switzerland)
  • Cell Biologics, Inc. (US)
  • PromoCell GmbH (Germany)
  • HemaCare Corporation (US)
  • ZenBio, Inc. (US)
  • STEMCELL Technologies, Inc. (Canada)
  • Corning Incorporated (US)
  • AllCells (US)
  • American Type Culture Collection (US)
  • Axol Bioscience Ltd. (UK)
  • iXCells Biotechnologies (US)
  • Neuromics (US)
  • StemExpress (US)
  • BioIVT (US)
  • ScienCell Research Laboratories, Inc. (US)
  • PPA Research Group, Inc. (US)
  • Creative Bioarray (US)
  • BPS Bioscience, Inc. (US)
  • Epithelix Sàrl (Switzerland)
  • ReachBio LLC (US)
  • AcceGen (US)
  • Sekisui XenoTech, LLC (US)
  • Biopredic International (France).

Research Coverage:

This report provides a detailed picture of the global primary cells market. It aims at estimating the size and future growth potential of the market across different segments, such as origin, type, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall primary cells market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, and opportunities.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AcceGen
  • BioIVT
  • Cell Biologics, Inc.
  • Epithelix Sàrl
  • Lonza
  • PPA Research Group, Inc.
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.2.2 Markets Covered
Figure 1 Primary Cells Market
1.2.3 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders
1.6 Report Comparison with the July 2018 Edition
1.6.1 Summary of Changes
1.6.2 Limitations of the Current Edition

2 Research Methodology
2.1 Research Data
2.2 Research Approach
Figure 2 Primary Cells Market: Research Design
2.2.1 Secondary Data
2.2.1.1 Key Data from Secondary Sources
2.2.2 Primary Data
Figure 3 Breakdown of Primary Interviews: by Company Type, Designation, and Region
2.2.2.1 Key Data from Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
Figure 4 Primary Cells Market: Bottom-Up Approach
2.3.2 Top-Down Approach
Figure 5 Primary Cells Market: Top-Down Approach
2.4 Market Breakdown and Data Triangulation
Figure 6 Data Triangulation Methodology
2.5 Assumptions for the Study

3 Executive Summary
Figure 7 Primary Cells Market, by Type, 2020 Vs. 2025 (USD Million)
Figure 8 Primary Cells Market, by Origin, 2020 Vs. 2025 (USD Million)
Figure 9 Primary Cells Market, by End-user, 2020 Vs. 2025 (USD Million)
Figure 10 Primary Cells Market, by Region, 2020 Vs. 2025 (USD Million)

4 Premium Insights
4.1 Primary Cells Market Overview
Figure 11 Increasing Cancer Research is Driving the Growth of the Primary Cells Market
4.2 Primary Cells Market, by Origin, 2020 Vs. 2025 (USD Million)
Figure 12 Human Primary Cells Segment to Dominate the Market in 2020
4.3 Primary Cells Market Share, by End-user, 2020 Vs. 2025 (USD Million)
Figure 13 Life Science Research Companies to Account for the Largest Share of the Primary Cells Market During the Forecast Period
4.4 Primary Cells Market: Geographic Growth Opportunities
Figure 14 Asia-Pacific to Register the Highest Growth Rate in the Primary Cells Market During the Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 15 Primary Cells Market: Drivers, Restraints, and Opportunities
5.2.1 Drivers
5.2.1.1 Increasing Cancer Research
Table 1 Projected Increase in the Number of Cancer Patients, 2015 Vs. 2018 Vs. 2035
Table 2 Research Funding for National Cancer Institute, 2015 Vs. 2017 (USD Million)
5.2.1.2 Advantages of Primary Human Cells Over Cell Lines
5.2.1.3 Increasing Demand for Monoclonal Antibodies
5.2.1.4 Rapid Growth in the Biotechnology and Biopharmaceutical Industries
Figure 16 Global Pharmaceutical & Biopharmaceutical R&D Expenditure, 2017-2024
5.2.1.5 Growing Focus on Personalized Medicine
Table 3 Growth in the Number of Personalized Medications, 2008-2016
5.2.1.6 Government Investments for Cell-Based Research
5.2.2 Restraints
5.2.2.1 Concerns Regarding Primary Cell Culture Contamination
5.2.2.2 Ethical Concerns Regarding Research in Cell Biology
5.2.3 Opportunities
5.2.3.1 Advancing Biomedical Research Using Primary Cells in 3D Cultures
5.3 COVID-19 Impact on the Primary Cells Market
5.4 Pricing Analysis
Table 4 Price of Primary Cells (2020)
5.5 Value Chain Analysis
Figure 17 Major Value is Added During the Manufacturing & Assembly Phase
5.6 Supply Chain Analysis
Figure 18 Distribution - A Strategy Preferred by Prominent Companies
5.7 Ecosystem Analysis of the Primary Cells Market
Figure 19 Ecosystem Analysis of the Primary Cells Market

6 Primary Cells Market, by Origin
6.1 Introduction
Table 5 Primary Cells Market, by Origin, 2018-2025 (USD Million)
6.2 Human Primary Cells
6.2.1 Increasing Prevalence of Cancer to Support Market Growth
Table 6 Human Primary Cells Market, by Region, 2018-2025 (USD Million)
6.3 Animal Primary Cells
6.3.1 Rising Investments in Animal Cell Research to Propel the Market Growth
Table 7 Animal Primary Cells Market, by Region, 2018-2025 (USD Million)

7 Primary Cells Market, by Type
7.1 Introduction
Table 8 Primary Cells Market, by Type, 2018-2025 (USD Million)
7.2 Hematopoietic Cells
7.2.1 Increasing Cancer Research & Funding to Propel the Market Growth
Table 9 Hematopoietic Cells, by Type
Table 10 Hematopoietic Cells Market, by Region, 2018-2025 (USD Million)
Table 11 North America: Hematopoietic Cells Market, by Country, 2018-2025 (USD Million)
Table 12 Europe: Hematopoietic Cells Market, by Country, 2018-2025 (USD Million)
Table 13 Asia-Pacific: Hematopoietic Cells Market, by Country, 2018-2025 (USD Million)
7.3 Dermatocytes
7.3.1 Rising Prevalence of Melanoma is a Key Factor Driving the Growth of this Segment
Table 14 Dermatocytes Market, by Region, 2018-2025 (USD Million)
Table 15 North America: Dermatocytes Market, by Country, 2018-2025 (USD Million)
Table 16 Europe: Dermatocytes Market, by Country, 2018-2025 (USD Million)
Table 17 Asia-Pacific: Dermatocytes Market, by Country, 2018-2025 (USD Million)
7.4 Gastrointestinal Cells
7.4.1 Increasing Incidence of Stomach Cancer to Bolster Market Growth
Table 18 Gastrointestinal Cells Market, by Region, 2018-2025 (USD Million)
Table 19 North America: Gastrointestinal Cells Market, by Country, 2018-2025 (USD Million)
Table 20 Europe: Gastrointestinal Cells Market, by Country, 2018-2025 (USD Million)
Table 21 Asia-Pacific: Primary Gastrointestinal Cells Market, by Country, 2018-2025 (USD Million)
7.5 Hepatocytes
Table 22 Global Liver Disorder Incidence
Table 23 Hepatocytes Market, by Region, 2018-2025 (USD Million)
Table 24 Hepatocytes Market, by Type, 2018-2025 (USD Million)
Table 25 North America: Hepatocytes Market, by Country, 2018-2025 (USD Million)
Table 26 Europe: Hepatocytes Market, by Country, 2018-2025 (USD Million)
Table 27 Asia-Pacific: Hepatocytes Market, by Country, 2018-2025 (USD Million)
7.5.1 Cryopreserved Hepatocytes
7.5.1.1 Longer Lifespan of Cryopreserved Hepatocytes Than Fresh Hepatocytes to Drive Market Growth
Table 28 Cryopreserved Hepatocytes Market, by Region, 2018-2025 (USD Million)
7.5.2 Fresh Hepatocytes
7.5.2.1 Stringent Regulations and Limited Availability of Fresh Hepatocytes to Limit Market Growth
Table 29 Fresh Hepatocytes Market, by Region, 2018-2025 (USD Million)
7.6 Lung Cells
7.6.1 Increasing Rate of Lung Cancer & Copd to Drive the Demand for Lung Cells
Table 30 Lung Cells Market, by Region, 2018-2025 (USD Million)
Table 31 North America: Lung Cells Market, by Country, 2018-2025 (USD Million)
Table 32 Europe: Lung Cells Market, by Country, 2018-2025 (USD Million)
Table 33 Asia-Pacific: Lung Cells Market, by Country, 2018-2025 (USD Million)
7.7 Renal Cells
7.7.1 Lack of Availability of Effective Renal Therapies to Propel Market Growth
Table 34 Renal Cells Market, by Region, 2018-2025 (USD Million)
Table 35 North America: Renal Cells Market, by Country, 2018-2025 (USD Million)
Table 36 Europe: Renal Cells Market, by Country, 2018-2025 (USD Million)
Table 37 Asia-Pacific: Renal Cells Market, by Country, 2018-2025 (USD Million)
7.8 Heart Cells
7.8.1 High Incidence of Cardiovascular Diseases is Supporting the Growth of this Segment
Table 38 Heart Cells Market, by Region, 2018-2025 (USD Million)
Table 39 North America: Heart Cells Market, by Country, 2018-2025 (USD Million)
Table 40 Europe: Heart Cells Market, by Country, 2018-2025 (USD Million)
Table 41 Asia-Pacific: Heart Cells Market, by Country, 2018-2025 (USD Million)
7.9 Musculoskeletal Cells
7.9.1 Rising Incidence of Musculoskeletal Disorders to Propel Market Growth
Table 42 Musculoskeletal Cells Market, by Region, 2018-2025 (USD Million)
Table 43 North America: Musculoskeletal Cells Market, by Country, 2018-2025 (USD Million)
Table 44 Europe: Musculoskeletal Cells Market, by Country, 2018-2025 (USD Million)
Table 45 Asia-Pacific: Musculoskeletal Cells Market, by Country, 2018-2025 (USD Million)
7.10 Other Primary Cells
Table 46 Other Primary Cells Market, by Region, 2018-2025 (USD Million)
Table 47 North America: Other Primary Cells Market, by Country, 2018-2025 (USD Million)
Table 48 Europe: Other Primary Cells Market, by Country, 2018-2025 (USD Million)
Table 49 Asia-Pacific: Other Primary Cells Market, by Country, 2018-2025 (USD Million)

8 Primary Cells Market, by End-user
8.1 Introduction
Table 50 Primary Cells Market, by End-user, 2018-2025 (USD Million)
8.2 Life Science Research Companies
8.2.1 Increasing Investments in Cell-Based Research to Drive the Market Growth
Table 51 Primary Cells Market for Life Science Research Companies, by Region, 2018-2025 (USD Million)
8.3 Research Institutes
8.3.1 Increasing Government Funding for Research and High Prevalence of Cancer are Driving Market Growth
Table 52 Primary Cells Market for Research Institutes, by Region, 2018-2025 (USD Million)

9 Primary Cells Market, by Region
9.1 Introduction
Table 53 Primary Cells Market, by Region, 2018-2025 (USD Million)
9.2 North America
Figure 20 North America: Cancer Incidence & Mortality, 2012-2035
Figure 21 North America: Primary Cells Market Snapshot
Table 54 North America: Primary Cells Market, by Country, 2018-2025 (USD Million)
Table 55 North America: Primary Cells Market, by Origin, 2018-2025 (USD Million)
Table 56 North America: Primary Cells Market, by Type, 2018-2025 (USD Million)
Table 57 North America: Hepatocytes Market, by Type, 2018-2025 (USD Million)
Table 58 North America: Primary Cells Market, by End-user, 2018-2025 (USD Million)
9.2.1 US
9.2.1.1 High R&D Spending and Growing Support for Stem Cell Research to Drive Market Growth in the US
Figure 22 US: Cancer Incidence & Mortality, 2012-2035
Table 59 US: Primary Cells Market, by Origin, 2018-2025 (USD Million)
Table 60 US: Primary Cells Market, by Type, 2018-2025 (USD Million)
Table 61 US: Hepatocytes Market, by Type, 2018-2025 (USD Million)
Table 62 US: Primary Cells Market, by End-user, 2018-2025 (USD Million)
9.2.2 Canada
9.2.2.1 Presence of Advanced R&D Infrastructure to Drive Market Growth
Table 63 Canada: Primary Cells Market, by Origin, 2018-2025 (USD Million)
Table 64 Canada: Primary Cells Market, by Type, 2018-2025 (USD Million)
Table 65 Canada: Primary Cells Market, by End-user, 2018-2025 (USD Million)
9.3 Europe
Figure 23 Europe: Cancer Incidence & Mortality, 2012-2035
Table 66 Europe: Primary Cells Market, by Country, 2018-2025 (USD Million)
Table 67 Europe: Primary Cells Market, by Origin, 2018-2025 (USD Million)
Table 68 Europe: Primary Cells Market, by Type, 2018-2025 (USD Million)
Table 69 Europe: Hepatocytes Market, by Type, 2018-2025 (USD Million)
Table 70 Europe: Primary Cells Market, by End-user, 2018-2025 (USD Million)
9.3.1 UK
9.3.1.1 Growth in the Life Sciences Industry to Drive Market Growth in the UK
Table 71 UK: Primary Cells Market, by Origin, 2018-2025 (USD Million)
Table 72 UK: Primary Cells Market, by Type, 2018-2025 (USD Million)
Table 73 UK: Primary Cells Market, by End-user, 2018-2025 (USD Million)
9.3.2 Germany
9.3.2.1 Increasing Life Science Research Activities to Support Market Growth
Table 74 Germany: Primary Cells Market, by Origin, 2018-2025 (USD Million)
Table 75 Germany: Primary Cells Market, by Type, 2018-2025 (USD Million)
Table 76 Germany: Primary Cells Market, by End-user, 2018-2025 (USD Million)
9.3.3 France
9.3.3.1 Robust Biotechnology Infrastructure in the Country to Support Market Growth
Table 77 France: Primary Cells Market, by Origin, 2018-2025 (USD Million)
Table 78 France: Primary Cells Market, by Type, 2018-2025 (USD Million)
Table 79 France: Primary Cells Market, by End-user, 2018-2025 (USD Million)
9.3.4 Italy
9.3.4.1 Increasing Number of Cell Biology Seminars and Conferences to Fuel the Adoption of Primary Cells
Table 80 Italy: Primary Cells Market, by Origin, 2018-2025 (USD Million)
Table 81 Italy: Primary Cells Market, by Type, 2018-2025 (USD Million)
Table 82 Italy: Primary Cells Market, by End-user, 2018-2025 (USD Million)
9.3.5 Rest of Europe
Table 83 Roe: Primary Cells Market, by Origin, 2018-2025 (USD Million)
Table 84 Roe: Primary Cells Market, by Type, 2018-2025 (USD Million)
Table 85 Roe: Primary Cells Market, by End-user, 2018-2025 (USD Million)
9.4 Asia-Pacific
Figure 24 Asia-Pacific: Cancer Incidence & Mortality, 2012-2035
Figure 25 Asia-Pacific: Primary Cells Market Snapshot
Table 86 APAC: Primary Cells Market, by Country, 2018-2025 (USD Million)
Table 87 APAC: Primary Cells Market, by Origin, 2018-2025 (USD Million)
Table 88 APAC: Primary Cells Market, by Type, 2018-2025 (USD Million)
Table 89 APAC: Hepatocytes, by Type, 2018-2025 (USD Million)
Table 90 APAC: Primary Cells Market, by End-user, 2018-2025 (USD Million)
9.4.1 China
9.4.1.1 Growing Focus on Cancer Therapeutics-Related Research to Bolster Market Growth
Table 91 China: Primary Cells Market, by Origin, 2018-2025 (USD Million)
Table 92 China: Primary Cells Market, by Type, 2018-2025 (USD Million)
Table 93 China: Primary Cells Market, by End-user, 2018-2025 (USD Million)
9.4.2 Japan
9.4.2.1 Government Initiatives to Propel Market Growth in Japan
Table 94 Japan: Primary Cells Market, by Origin, 2018-2025 (USD Million)
Table 95 Japan: Primary Cells Market, by Type, 2018-2025 (USD Million)
Table 96 Japan: Primary Cells Market, by End-user, 2018-2025 (USD Million)
9.4.3 Rest of Asia-Pacific
Table 97 Roapac: Primary Cells Market, by Origin, 2018-2025 (USD Million)
Table 98 Roapac: Primary Cells Market, by Type, 2018-2025 (USD Million)
Table 99 Roapac: Primary Cells Market, by End-user, 2018-2025 (USD Million)
9.5 Rest of the World
Table 100 RoW: Primary Cells Market, by Origin, 2018-2025 (USD Million)
Table 101 RoW: Primary Cells Market, by Type, 2018-2025 (USD Million)
Table 102 RoW: Hepatocytes Market, by Type, 2018-2025 (USD Million)
Table 103 RoW: Primary Cells Market, by End-user, 2018-2025 (USD Million)

10 Competitive Landscape
10.1 Overview
Figure 26 Key Developments in the Primary Cells Market (2017 to 2020)
10.2 Market Share Analysis
Figure 27 Primary Cells Market Share, by Key Player (2019)
10.3 Competitive Scenario
10.3.1 Product Launches
Table 104 Product Launches
10.3.2 Agreements
Table 105 Agreements
10.3.3 Expansions
Table 106 Expansions
10.3.4 Partnerships
Table 107 Partnerships
10.3.5 Acquisitions
Table 108 Acquisitions

11 Company Evaluation Matrix and Company Profiles
11.1 Company Evaluation Matrix Definitions and Methodology
11.1.1 Vendor Exclusion Criteria
11.1.2 Stars
11.1.3 Emerging Leaders
11.1.4 Pervasive Players
11.1.5 Participants
Figure 28 Primary Cells Market: Competitive Leadership Mapping, 2019
11.2 Competitive Leadership Mapping for Start-Ups (2019)
11.2.1 Progressive Companies
11.2.2 Starting Blocks
11.2.3 Responsive Companies
11.2.4 Dynamic Companies
Figure 29 Primary Cells Market: Competitive Leadership Mapping for Start-Ups, 2019
11.3 Company Profiles
(Business Overview, Products Offered, Recent Developments, Analyst's View)*
11.3.1 Thermo Fisher Scientific, Inc.
Figure 30 Thermo Fisher Scientific, Inc.: Company Snapshot (2019)
11.3.2 Merck KGaA
Figure 31 Merck KGaA: Company Snapshot (2019)
11.3.3 Lonza
Figure 32 Lonza: Company Snapshot (2019)
11.3.4 Promocell GmbH
11.3.5 Corning Incorporated
Figure 33 Corning Incorporated: Company Snapshot (2019)
11.3.6 American Type Culture Collection (Atcc)
11.3.7 Cell Biologics, Inc.
11.3.8 Hemacare Corporation (A Charles River Laboratories, Inc. Company)
Figure 34 Charles River Laboratories, Inc.: Company Snapshot (2019)
11.3.9 Zenbio, Inc.
11.3.10 Stem Cell Technologies, Inc.
11.3.11 Allcells
11.3.12 Axol Bioscience Ltd.
11.3.13 Ixcells Biotechnologies
11.3.14 Neuromics
11.3.15 Stemexpress
11.3.16 BioIVT
11.3.17 Sciencell Research Laboratories, Inc.
11.3.18 Sekisui Xenotech, LLC
11.3.19 Ppa Research Group, Inc.
11.3.20 Creative Bioarray
11.3.21 BPS Bioscience, Inc.
11.3.22 Epithelix Sàrl
11.3.23 Reachbio LLC
11.3.24 Accegen
11.3.25 Biopredic International

*Business Overview, Products Offered, Recent Developments, Analyst's View Might Not be Captured in Case of Unlisted Companies.

12 Appendix
12.1 Insights from Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: The Subscription Portal
12.4 Available Customizations

Note: Product cover images may vary from those shown

Loading
LOADING...

  • AcceGen
  • AllCells
  • American Type Culture Collection
  • Axol Bioscience Ltd.
  • BioIVT
  • Biopredic International
  • BPS Bioscience, Inc.
  • Cell Biologics, Inc.
  • Corning Incorporated
  • Creative Bioarray
  • Epithelix Sàrl
  • HemaCare Corporation
  • iXCells Biotechnologies
  • Lonza
  • Merck KGaA
  • Neuromics
  • PPA Research Group, Inc.
  • PromoCell GmbH
  • ReachBio LLC
  • ScienCell Research Laboratories, Inc.
  • Sekisui XenoTech, LLC
  • STEMCELL Technologies, Inc.
  • StemExpress
  • Thermo Fisher Scientific, Inc.
  • ZenBio, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll